Methods and compositions for treating eukaryotic infections via altering aggregation dynamics of raptor/kog1

Abstract

Methods and compositions for activating TORC1 aggregate formation in a fungi or a parasite, wherein TORC1 aggregate formation inhibits growth of the fungi or parasite. TORC1 aggregate formation may be activated using small molecules or other agents, and said agents may be used to treat or prevent a disease or condition associated with the fungi and parasite. The agent may target Kog1 of TORC1, e.g., the agent may directly or indirectly inhibit Kog1 leading to aggregation of the TORC1 complex.

What is claimed is: 
     
         1 . A method of treating a candidiasis infection associated with a  Candida  fungus in a human or animal in need thereof, said method comprising:
 a. identifying a human or animal in need thereof with a candidiasis infection associated with a  Candida  fungus, and   b. administering an effective amount of a small molecule to the human or animal in need thereof with the candidiasis infection associated with a  Candida  fungus;
 wherein the small molecule activates Kog1 aggregate formation in the  Candida  fungus, wherein the Kog1 aggregate formation inhibits growth of the  Candida  fungus. 
   
     
     
         2 . The method of  claim 1 , wherein the small molecule binds Kog1. 
     
     
         3 . The method of  claim 1 , wherein the small molecule comprises metformin, PT 1, salicylsalicylic acid, Phenformin, AICAR, A-769662, Acadesine, orsomorphin, 1,1-Dimethylbiguanide hydrochloride, or BML-275. 
     
     
         4 . The method of  claim 1 , further comprising administering an antifungal drug to the human or animal as a co-treating.